DXB Media thread., page-12

Hi BT & yes we didn’t get any safety signals there in critically unwell patients (ICU admissions), but the ARB/ACEi arm was stopped in a global COVID platform trial. The other thing is that DMX-200 could be useful in pneumonia & ILD (interstitial lung disease). It wasn’t our IP that stopped this arm on safety signals, so for sure at the time, incredibly disappointing for us, but all the data adds up. The FDA must like it anyway to allow kids on the trial come March 2024.